Clinical AI Assistants: What Evidence to Ask For Before Deployment
Hospitals evaluating AI assistants for clinicians should ask for validation on their own patients, not only a vendor demo.
AI assistants for clinicians now draft summaries, answer questions about guidelines and help search the record. The demos are persuasive. The harder question for a hospital is what evidence supports using one with real patients.
This article lays out a practical list of questions, based on general principles of software validation and risk management.
Start with the task, not the tool
“Clinical AI assistant” covers very different products. Drafting a patient letter carries different risk than suggesting a drug dose. The first step is to write down the exact task the tool will perform, and the exact tasks it must not perform.
A task statement should include:
- Who uses the tool, such as physicians, nurses or administrative staff.
- What input it receives and what output it produces.
- Where its output goes, for example into a draft or directly into the record.
- What happens if the output is wrong.
Why the intended use matters
Regulators generally look at the intended use of software. A tool that only summarizes text for a clinician who reads the source may sit in a different category than a tool that recommends a diagnosis. Hospitals should ask the vendor for its regulatory position in writing and not infer it from the product name.
What good evidence looks like
A vendor demonstration uses selected examples. Evidence needs to be systematic.
Performance on representative data
Ask how the tool was tested, on which data and with which measures. Results from one hospital system may not transfer to another with different documentation habits, patient populations or languages. The best evidence includes a local evaluation: run the tool on a sample of your own cases, with clinicians scoring the output.
Failure modes, not only averages
An average accuracy figure hides the cases that matter. Ask what kinds of errors occur, how severe they can be and whether the tool signals uncertainty. For language models, ask specifically how the tool handles missing information and whether it can produce statements not supported by the source record.
A tool that is usually right and sometimes confidently wrong needs a different workflow than a tool that is usually right and says when it is unsure.
Governance after go-live
Validation is not a one-time event. Models, record systems and clinical practice change.
- Assign an owner. A named clinical lead and a technical lead should be accountable.
- Define human review. Specify which outputs a clinician must read before use.
- Collect incidents. Make it easy for staff to report wrong or unsafe outputs.
- Monitor over time. Review samples regularly and re-check after software updates.
Frameworks such as the NIST AI Risk Management Framework offer a structure for this work. They are general rather than clinical, but they help teams organize questions about mapping, measuring and managing risk.
Data protection and security
Ask where patient data is processed and stored, whether it is used to train the vendor’s models and what happens when the contract ends. These questions belong in the contract, not only in the sales conversation.
A short checklist
Before approving a pilot, a hospital can check:
- The task and exclusions are written down.
- The regulatory position is documented.
- A local evaluation plan exists, with clinician scoring.
- Human review and incident reporting are defined.
- Data handling terms are agreed.
None of this slows adoption unreasonably. It shortens the time between a pilot and a confident decision, because the team knows in advance what result would count as success and what would count as a reason to stop.